Leading research into ME/CFS

Company Name

News and Events

Dr Luis Nacul appointed to new position in Canada

The CureME team is delighted to share the news that our Principal Investigator Dr Luis Nacul has been appointed as Medical Director of the Complex Chronic Diseases Program at British Columbia Women’s Hospital in Vancouver, Canada. This appointment is the result of close collaboration with colleagues in Canada, and comes after Luis’s term as International […]

Read more

Laboratory results published

We are delighted to announce the publication of our new paper, “Cellular immune function in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).” This publication captures many results from Phase 1 of our NIH R01 study, with analysis conducted on samples collected in 2013-2017. Immunology and virology continues in our renewal award, with -omics work nearing publication. The […]

Read more

UKMEB wins Biobanking Award

The CureME team at the London School of Hygiene & Tropical Medicine (LSHTM) is thrilled to have received an Honourable Mention for Biobank of the Year 2018, presented on Tuesday 27th November at the UK Biobanking Showcase in London. The Showcase is run each year by the UKCRC Tissue Directory and Coordination Centre, and comprised […]

Read more

Statement from the team after the CMRC 2018 Conference

Three members of the CureME Team presented at the UK CFS/ME Research Collaborative Conference in Bristol last week. It was an excellent event, with many important presentations given.   We were delighted that our presentations were well-received, and that researchers in the field were keen to hear about our participant networks and biorepository infrastructure, in […]

Read more

Funding Call for Researchers

In November 2017 – January 2018, the UK ME/CFS Biobank (UKMEB) raised around £17,000 from a crowdfunding campaign. The campaign was conducted with the assistance of partner organisations and charities. We have decided to use these funds to release samples and data from the UKMEB free of charge to selected researchers. We want to enable […]

Read more

Welcome back Jack!

The CureME team is delighted to confirm the re-appointment of Jack Butterworth as our Project Manager until the end of the current NIH-funded award.  Jack brings additional energy and drive to the team, and challenges our ambition for ME/CFS research. Jack has been working for us since last June, but joins us permanently this week […]

Read more

R21 Success

In December 2017 we recruited 60 more participants, healthy controls and participants with ME/CFS for our R21 saliva- and urine-based study (funded by the NIH). This study will enable comprehensive assessments of cases of ME/CFS, using saliva and urine samples, at regular monthly intervals for the next six months. This greatly enhances the chances of […]

Read more

NICE – Initial Engagement Meeting

Statement from CureME Director and Principal Investigator Dr Luis Nacul, who represented CureME and the LSHTM at yesterday’s National Institute for Health and Care Excellence initial engagement meeting on new guidelines for ME/CFS: “The meeting was positive and NICE seems committed to fully engaging people with ME/CFS among a wide range of stakeholders. There seems to be […]

Read more

2017 Christmas Appeal success!

The UK ME/CFS Biobank entered 2018 with a bang! We are delighted to announce that the Christmas Appeal grand total is a whopping £17,910 (with the possibility of a slight increase). These donations will allow us to release more Biobank samples in 2018 and continue our longitudinal study. A major shout out must go to […]

Read more

CureME’s annual newsletter 2017

Our 2017 Annual Newsletter with updates on the Biobank and our research can be found here. We wish you all the best for 2018 and look forward to keeping you posted on an exciting year ahead!

Read more